Global Tyrosine Kinase Inhibitors Market 2019-2023: Market will Register a CAGR of More than 8% - Key Vendors are Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson & Johnson, Novartis & Pfizer
Friday, 11 January 2019 Dublin, Jan. 11, 2019 (GLOBE NEWSWIRE) -- The "Global Tyrosine Kinase Inhibitors Market 2019-2023" report has been added to *ResearchAndMarkets.com's* offering.
The tyrosine kinase inhibitors market will register a CAGR of more than 8% by 2023.
Strategic alliances to trend in the market. The growing prevalence of various diseases increases the demand for innovative therapeutics. TKI therapeutics are one of the most reliable therapeutic options for the treatment of cancer and age-related diseases such as RVO.
*Recent approvals of TKIs*
Many TKI therapeutic candidates are gaining approval due to their high safety profile and efficacy. The therapeutics that are in last stage of development are expected to get marketing approval during forecast period.
*Side effects of TKIs*
Despite highly efficacious, TKIs are associated with a spectrum of side effects such as fatigue, muscle cramps, nausea, vomiting, and diarrhea.
The market appears to be fragmented and with the presence of several companies including Novartis and Pfizer, the competitive environment is quite intense. Factors such as the rising strategic alliances and the recent approvals of TKIs, will provide considerable growth opportunities to tyrosine kinase inhibitors manufactures.
Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson & Johnson, Novartis, and Pfizer are some of the major companies covered in this report.
· Vendors covered
· Vendor classification
· Market positioning of vendors
· Bristol-Myers Squibb
· F. Hoffmann-La Roche
· Johnson & Johnson
· PfizerFor more information about this report visit https://www.researchandmarkets.com/research/q9h4f5/global_tyrosine?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Enzymes